mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.8 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |